Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet] JAMA today published outcomes from a study evaluating the safety and efficacy of the Insulet Omnipod 5 in adults with type 2 diabetes.

THOUGHTS LIKE SHOWER THOUGHTS AND EVERY SITE CHANGE. I WOULD JUST KIND OF LIKE TALK ABOUT MY DIABETES. RIGHT NOW WE’RE GOING TO TAKE THE STICKIES OFF THE INSULIN PUMP OR OMNIPOD SITE CHANGES ...

Zach White, 23, and Elise Scalfani, 26, connected on a social media account for people living with type 1 diabetes — now they ...

Insulet Corporation’s PODD rapid commercial expansion and increasing market access capabilities for its Omnipod platform are poised to help it grow in the upcoming quarters. The rising adoption ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

Wall Street analysts expect Insulet (PODD) to post quarterly earnings of $1.05 per share in its upcoming report, which indicates a year-over-year decline of 25%. Revenues are expected to be $581.65 ...

About the Sustainable SITES Initiative and the SITES Rating System The Sustainable SITES Initiative is a set of comprehensive, voluntary guidelines together with a rating system that assesses the ...

One of the trends we saw in this month’s data, growth for news sites, was also reflected in Similarweb’s Digital 100 report on the fastest-growing websites and apps of 2024. For example ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to share on Reddit (Opens in new window) The top affair sites might cater to you in ways you can ...